Adapting the roadmapping approach to science-intensive organizations: Lessons from a drug development program for neglected diseases

This paper discusses a roadmapping approach (RMA) adopted on a program on drug discovery and development for neglected diseases. This experience led to changes in traditional RMA that revealed special potential for science-intensive environments: (i) conduct the roadmapping process in parallel for a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of engineering and technology management 2019-04, Vol.52, p.3-15
Main Authors: Freitas, Jonathan Simões, Bagno, Raoni Barros, Bertollo, Caryne Margotto, Alves, Tânia Maria de Almeida, Zani, Carlos Leomar, Cheng, Lin Chih, Gonçalves, Carlos Alberto
Format: Article
Language:English
Subjects:
Contingency
Drug discovery and development
Innovation in science-intensive organizations
Neglected diseases
Pathology
Pharmacology
Roadmapping
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This paper discusses a roadmapping approach (RMA) adopted on a program on drug discovery and development for neglected diseases. This experience led to changes in traditional RMA that revealed special potential for science-intensive environments: (i) conduct the roadmapping process in parallel for alternative areas of interest; (ii) start the roadmapping process by focusing on the consolidated technological paths; (iii) construct roadmaps to highlight organizational strengths and weaknesses; and (iv) consider the sectoral contingencies to enhance the managerial approaches. Among the implications, some literature paradigms are contrasted by contingency adapting RMA, changing workshop dynamics; and adopting a slow inside-out strategizing approach.
ISSN:0923-4748
1879-1719
DOI:10.1016/j.jengtecman.2018.01.006